Icotrokinra hydrochloride

Short Description:

API’s Name CAS No. US DMF Patent Expiry Date (US) Current Status 
Icotrokinra hydrochloride 3049491-48-4

 

[Indication] 

  • Moderate-to-severe plaque psoriasis: For the treatment of moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older weighing at least 40 kg who are candidates for systemic therapy or phototherapy.


Product Detail

Product Tags


  • Previous:
  • Next:

  • Write your message here and send it to us

    Products categories